[1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone
C22H21FN2O2 — CID 71595667
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone
[1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone (PubChem CID 71595667) has the molecular formula C22H21FN2O2 and a molecular weight of 364.42 g/mol. Its IUPAC name is [1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone.
Molecular Properties
| Compound Name | [1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone |
|---|---|
| PubChem CID | 71595667 |
| Molecular Formula | C22H21FN2O2 |
| Molecular Weight | 364.42 g/mol |
| Exact Mass | 364.16 |
| IUPAC Name | [1-[(4-fluorophenyl)methyl]indol-3-yl]-[2-(1-hydroxyethenyl)pyrrolidin-1-yl]methanone |
| SMILES | C=C(O)C1CCCN1C(=O)c1cn(Cc2ccc(F)cc2)c2ccccc12 |
| InChI | InChI=1S/C22H21FN2O2/c1-15(26)20-7-4-12-25(20)22(27)19-14-24(21-6-3-2-5-18(19)21)13-16-8-10-17(23)11-9-16/h2-3,5-6,8-11,14,20,26H,1,4,7,12-13H2 |
| InChIKey | UULHUUDVJOHIFX-UHFFFAOYSA-N |
| XLogP | 4.51 |
| TPSA | 45.47 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 364.42 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71595667 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.